qualifications for glp 1 GLP-1 RAs hold promise pediatric obesity, MASLD; barriers persist | AAP News Nutritional priorities to support GLP-1

10.2337/db16-0032 62 JonesG

But of the non-weight related benefits, what are you most excited about

In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss

Insulin icodec, also known as Icodec, is a once-weekly basal insulin designed to help manage blood sugar levels in people with diabetes

Based on their pharmacokinetic profile, they are divided into short-acting agonists (exenatide and lixisenatide) and long-acting agonists (liraglutide

Together, these three strains are delivered at 500 million AFU per serving alongside chicory inulin, a prebiotic fiber that feeds beneficial gut bacteria